Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment

Fetal Hydrops Clinical Trial

Official title: Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment

Status Not yet recruiting

Clinical Trial Summary

Based on multi-center clinical research resources, a large-scale prospective cohort study will be conduted to make a more accurate diagnosis and intervention plan of Non-immune fetal hydrops (NIFH), and then establish NIFH accurate treatment strategy which is suitable for China's national conditions.

Clinical Trial Description

1. Etiological study of Non-immune fetal hydrops(NIFH):

1. Etiological study of NIFH in mid-pregnancy period;

2. Etiological study of NIFH and hygroma colli in first trimester;

3. Value assessment of technology for exome sequencing in diagnosis of NIFH;

2. The accuracy of NIFH intrauterine intervention and its effect assessment:

1. Perinatal outcomes of NIFH ;

2. The effect of intrauterine treatments. ;

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Edema
• Fetal Hydrops
• Hydrops Fetalis

• NCT number: NCT02956564
• Study type: Interventional
• Source: Shanghai First Maternity and Infant Hospital
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 2016
• Completion date: August 2018